Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy

OBJECTIVES: Dolutegravir (DTG), a second-generation integrase inhibitor, is an effective treatment for HIV but its safety and efficacy are not well established in pregnancy. Here, we assess maternal and infant outcomes of mother–infant pairs using DTG-containing regimens during pregnancy. METHODS: W...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:AIDS
Päätekijät: Grayhack, Clara, Sheth, Anandi, Kirby, Olivia, Davis, Jennifer, Sibliss, Kedesha, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Laguerre, Roberta, Rana, Aadia, Badell, Martina, Momplaisir, Florence
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2018
Aiheet:
Clinical Science: Concise Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125741/
https://ncbi.nlm.nih.gov/pubmed/29944472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001931
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia